The Channel Syndicate, part of SCOR’s Specialty Insurance platform, today announces it has agreed a reinsurance to close for its 2017 and prior years of account, subject to regulatory approval.
Life insurance products have an important role to play in supporting consumers’ dreams and aspirations as well as in mitigating their worst nightmares.
SCOR Global Life a réalisé un investissement stratégique dans BioSerenity, une entreprise française qui offre des solutions de santé visant à optimiser le parcours de soins de patients atteints de certaines maladies c
Cette publication présente quelques informations globales sur les maladies rénales, leurs conséquences, les traitements, les thérapies de remplacement et propose des éléments d’approche en sélection des risques et en
This publication presents some global information on kidney diseases, the definitions and basic notions, protective treatments, renal replacement therapies, disease progression information as well as proposed underwri
A weather analysis of China’s agricultural production risk
In order to achieve the objectives of the “Quantum Leap” strategic plan, SCOR Global Life evolves its organisation and announces promotions in its Global Markets team.
